Trial aims to tame serious disease while dodging steroid side effects
NCT ID NCT06983821
Summary
This study is testing a new treatment plan for a serious autoimmune disease that attacks the kidneys. It compares a much shorter, lower-dose course of steroids (4 weeks) against the current standard treatment (6+ months) to see if it works just as well. The main goal is to see if this new approach can control the disease while causing fewer serious infections and other steroid-related side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St-Joseph's Hospital
NOT_YET_RECRUITINGHamilton, Ontario, Canada
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.